Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1993 Apr;30(4):273–279. doi: 10.1136/jmg.30.4.273

Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia.

S Humphries 1, L King-Underwood 1, V Gudnason 1, M Seed 1, S Delattre 1, V Clavey 1, J C Fruchart 1
PMCID: PMC1016331  PMID: 8098067

Abstract

We have determined the relative allele frequency and estimated linkage disequilibrium between six DNA polymorphisms of the low density lipoprotein (LDL) receptor gene. Polymorphisms were detected using the enzymes SfaNI, TaqI, StuI, HincII, AvaII, and NcoI after DNA amplification by the polymerase chain reaction. Strong linkage disequilibrium was detected between many of the pair wise comparisons in a sample of 60 patients heterozygous for familial hypercholesterolaemia (FH). Using the enzymes HincII, NcoI, and SfaNI, 85% of patients were heterozygous for at least one polymorphism and thus potentially informative for cosegregation studies. The polymorphisms were used to follow the inheritance of the defective allele of the LDL receptor gene in the relatives of a patient with FH. Assays of LDL receptor activity on lymphoblastoid cell lines from two members of the family was used to confirm that the proband, but not the hypercholesterolaemic brother, had a defect in the LDL receptor. In the family, none of the children had inherited the allele of the LDL receptor gene inferred to be defective. The problems associated with this cosegregation approach to identify relatives of patients with a clinical diagnosis of FH are discussed.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aalto-Setälä K., Gylling H., Miettinen T., Kontula K. Identification of a deletion in the LDL receptor gene. A Finnish type of mutation. FEBS Lett. 1988 Mar 28;230(1-2):31–34. doi: 10.1016/0014-5793(88)80635-5. [DOI] [PubMed] [Google Scholar]
  2. Benhamamouch S., Kuznierz J. P., Agnani G., Marzin D., Lecerf J. M., Fruchart J. C., Clavey V. Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay. Biochim Biophys Acta. 1989 Mar 14;1002(1):45–53. doi: 10.1016/0005-2760(89)90062-3. [DOI] [PubMed] [Google Scholar]
  3. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Chakravarti A., Buetow K. H., Antonarakis S. E., Waber P. G., Boehm C. D., Kazazian H. H. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet. 1984 Nov;36(6):1239–1258. [PMC free article] [PubMed] [Google Scholar]
  6. Christensen B., Glueck C., Kwiterovich P., Degroot I., Chase G., Heiss G., Mowery R., Tamir I., Rifkind B. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res. 1980 Mar;14(3):194–202. doi: 10.1203/00006450-198003000-00004. [DOI] [PubMed] [Google Scholar]
  7. Cuthbert J. A., East C. A., Bilheimer D. W., Lipsky P. E. Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. N Engl J Med. 1986 Apr 3;314(14):879–883. doi: 10.1056/NEJM198604033141404. [DOI] [PubMed] [Google Scholar]
  8. Di Minno G., Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis. 1990 Jan-Feb;10(1):1–7. doi: 10.1161/01.atv.10.1.1. [DOI] [PubMed] [Google Scholar]
  9. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  10. Goldstein J. L., Brown M. S. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy. Med Clin North Am. 1982 Mar;66(2):335–362. doi: 10.1016/s0025-7125(16)31424-9. [DOI] [PubMed] [Google Scholar]
  11. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1533–1543. doi: 10.1172/JCI107331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hobbs H. H., Brown M. S., Russell D. W., Davignon J., Goldstein J. L. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N Engl J Med. 1987 Sep 17;317(12):734–737. doi: 10.1056/NEJM198709173171204. [DOI] [PubMed] [Google Scholar]
  14. Hobbs H. H., Russell D. W., Brown M. S., Goldstein J. L. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet. 1990;24:133–170. doi: 10.1146/annurev.ge.24.120190.001025. [DOI] [PubMed] [Google Scholar]
  15. Horsthemke B., Beisiegel U., Dunning A., Havinga J. R., Williamson R., Humphries S. Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia. Eur J Biochem. 1987 Apr 1;164(1):77–81. doi: 10.1111/j.1432-1033.1987.tb10995.x. [DOI] [PubMed] [Google Scholar]
  16. Horsthemke B., Dunning A., Humphries S. Identification of deletions in the human low density lipoprotein receptor gene. J Med Genet. 1987 Mar;24(3):144–147. doi: 10.1136/jmg.24.3.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Horsthemke B., Kessling A. M., Seed M., Wynn V., Williamson R., Humphries S. E. Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia. Hum Genet. 1985;71(1):75–78. doi: 10.1007/BF00295672. [DOI] [PubMed] [Google Scholar]
  18. Humphries S. E., Donald J. A., McFadden J. J., Shull S., Williamson R., Jowett N. I., Galton D. J., Julsrud J. O., Berg K., Heiberg A. The use of polymorphic DNA and protein markers for the third complement component for determining linkage of familial hypercholesterolaemia. Atherosclerosis. 1984 Sep;52(3):267–278. doi: 10.1016/0021-9150(84)90056-x. [DOI] [PubMed] [Google Scholar]
  19. Innerarity T. L., Weisgraber K. H., Arnold K. S., Mahley R. W., Krauss R. M., Vega G. L., Grundy S. M. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6919–6923. doi: 10.1073/pnas.84.19.6919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jeffreys A. J., Brookfield J. F., Semeonoff R. Positive identification of an immigration test-case using human DNA fingerprints. 1985 Oct 31-Nov 6Nature. 317(6040):818–819. doi: 10.1038/317818a0. [DOI] [PubMed] [Google Scholar]
  21. Kessling A. M., Seed M., Taylor R., Wynn V., Humphries S. E. Rising cholesterol levels in children with familial hypercholesterolaemia. Biomed Pharmacother. 1990;44(7):373–379. doi: 10.1016/0753-3322(90)90091-m. [DOI] [PubMed] [Google Scholar]
  22. King-Underwood L., Gudnason V., Humphries S., Seed M., Patel D., Knight B., Soutar A. Identification of the 664 proline to leucine mutation in the low density lipoprotein receptor in four unrelated patients with familial hypercholesterolaemia in the UK. Clin Genet. 1991 Jul;40(1):17–28. doi: 10.1111/j.1399-0004.1991.tb03064.x. [DOI] [PubMed] [Google Scholar]
  23. Koivisto P. V., Koivisto U. M., Miettinen T. A., Kontula K. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. Arterioscler Thromb. 1992 May;12(5):584–592. doi: 10.1161/01.atv.12.5.584. [DOI] [PubMed] [Google Scholar]
  24. Kunkel L. M., Smith K. D., Boyer S. H., Borgaonkar D. S., Wachtel S. S., Miller O. J., Breg W. R., Jones H. W., Jr, Rary J. M. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1245–1249. doi: 10.1073/pnas.74.3.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kwiterovich P. O., Jr, Fredrickson D. S., Levy R. I. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest. 1974 May;53(5):1237–1249. doi: 10.1172/JCI107670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lehrman M. A., Schneider W. J., Südhof T. C., Brown M. S., Goldstein J. L., Russell D. W. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science. 1985 Jan 11;227(4683):140–146. doi: 10.1126/science.3155573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leitersdorf E., Chakravarti A., Hobbs H. H. Polymorphic DNA haplotypes at the LDL receptor locus. Am J Hum Genet. 1989 Mar;44(3):409–421. [PMC free article] [PubMed] [Google Scholar]
  28. Leonard J. V., Whitelaw A. G., Wolff O. H., Lloyd J. K., Slack J. Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J. 1977 Jun 18;1(6076):1566–1568. doi: 10.1136/bmj.1.6076.1566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Myant N. B., Gallagher J. J., Knight B. L., McCarthy S. N., Frostegård J., Nilsson J., Hamsten A., Talmud P., Humphries S. E. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. Arterioscler Thromb. 1991 May-Jun;11(3):691–703. doi: 10.1161/01.atv.11.3.691. [DOI] [PubMed] [Google Scholar]
  30. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 1986 Aug;73(4):320–326. doi: 10.1007/BF00279094. [DOI] [PubMed] [Google Scholar]
  31. Orita M., Sekiya T., Hayashi K. DNA sequence polymorphisms in Alu repeats. Genomics. 1990 Oct;8(2):271–278. doi: 10.1016/0888-7543(90)90282-y. [DOI] [PubMed] [Google Scholar]
  32. Saiki R. K., Walsh P. S., Levenson C. H., Erlich H. A. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6230–6234. doi: 10.1073/pnas.86.16.6230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schmitz G., Wulf G., Brüning T., Assmann G. Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes. Clin Chem. 1987 Dec;33(12):2195–2203. [PubMed] [Google Scholar]
  34. Schuster H., Stiefenhofer B., Wolfram G., Keller C., Humphries S., Huber A., Zöllner N. Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia. Hum Genet. 1989 Apr;82(1):69–72. doi: 10.1007/BF00288276. [DOI] [PubMed] [Google Scholar]
  35. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. doi: 10.1016/s0140-6736(69)90930-1. [DOI] [PubMed] [Google Scholar]
  36. Soria L. F., Ludwig E. H., Clarke H. R., Vega G. L., Grundy S. M., McCarthy B. J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989 Jan;86(2):587–591. doi: 10.1073/pnas.86.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Soutar A. K. A polymorphism in exon 2 of the human LDL-receptor gene (LDLR). Nucleic Acids Res. 1991 Aug 11;19(15):4314–4314. doi: 10.1093/nar/19.15.4314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sun X. M., Webb J. C., Gudnason V., Humphries S., Seed M., Thompson G. R., Knight B. L., Soutar A. K. Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler Thromb. 1992 Jul;12(7):762–770. doi: 10.1161/01.atv.12.7.762. [DOI] [PubMed] [Google Scholar]
  39. Talmud P., Tybjaerg-Hansen A., Bhatnagar D., Mbewu A., Miller J. P., Durrington P., Humphries S. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis. 1991 Aug;89(2-3):137–141. doi: 10.1016/0021-9150(91)90053-6. [DOI] [PubMed] [Google Scholar]
  40. Tamir I., Heiss G., Glueck C. J., Christensen B., Kwiterovich P., Rifkind B. M. Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study. J Chronic Dis. 1981;34(1):27–39. doi: 10.1016/0021-9681(81)90079-5. [DOI] [PubMed] [Google Scholar]
  41. Tartof K. D. Unequal crossing over then and now. Genetics. 1988 Sep;120(1):1–6. doi: 10.1093/genetics/120.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Taylor R., Bryant J., Gudnason V., Sigurdsson G., Humphries S. A study of familial hypercholesterolaemia in Iceland using RFLPs. J Med Genet. 1989 Aug;26(8):494–498. doi: 10.1136/jmg.26.8.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Taylor R., Jeenah M., Seed M., Humphries S. Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus. J Med Genet. 1988 Oct;25(10):653–659. doi: 10.1136/jmg.25.10.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tolleshaug H., Hobgood K. K., Brown M. S., Goldstein J. L. The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor. Cell. 1983 Mar;32(3):941–951. doi: 10.1016/0092-8674(83)90079-x. [DOI] [PubMed] [Google Scholar]
  45. Top B., Koeleman B. P., Gevers Leuven J. A., Havekes L. M., Frants R. R. Rearrangements in the LDL receptor gene in Dutch familial hypercholesterolemic patients and the presence of a common 4 kb deletion. Atherosclerosis. 1990 Aug;83(2-3):127–136. doi: 10.1016/0021-9150(90)90158-f. [DOI] [PubMed] [Google Scholar]
  46. Tybjaerg-Hansen A., Gallagher J., Vincent J., Houlston R., Talmud P., Dunning A. M., Seed M., Hamsten A., Humphries S. E., Myant N. B. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis. 1990 Jan;80(3):235–242. doi: 10.1016/0021-9150(90)90031-d. [DOI] [PubMed] [Google Scholar]
  47. Webb J. C., Sun X. M., Patel D. D., McCarthy S. N., Knight B. L., Soutar A. K. Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia. J Lipid Res. 1992 May;33(5):689–698. [PubMed] [Google Scholar]
  48. Wight T. N. Cell biology of arterial proteoglycans. Arteriosclerosis. 1989 Jan-Feb;9(1):1–20. doi: 10.1161/01.atv.9.1.1. [DOI] [PubMed] [Google Scholar]
  49. Yamamoto T., Davis C. G., Brown M. S., Schneider W. J., Casey M. L., Goldstein J. L., Russell D. W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984 Nov;39(1):27–38. doi: 10.1016/0092-8674(84)90188-0. [DOI] [PubMed] [Google Scholar]
  50. Zuliani G., Hobbs H. H. Dinucleotide repeat polymorphism at the 3' end of the LDL receptor gene. Nucleic Acids Res. 1990 Jul 25;18(14):4300–4300. doi: 10.1093/nar/18.14.4300. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES